Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

Raysearch Laboratories AB / Equity Bottom-Up

<ul><li>RaySearch’s Q2 figures were largely known following the July profit warning.</li><li>More importantly, management reiterates its full-year EBIT margin target of +25%, while the recently announced US orders provide a strong signal that the Q2 delays were indeed timing related.</li><li>We continue to expect a significantly stronger H2 2026.</li></ul>

RaySearch’s Q2 figures were largely known following the July profit warning.More importantly, management reiterates its full-year EBIT margin target of +25%, while the recently announced US orders provide a strong signal that the Q2 delays were indeed timing related.We continue to expect a significantly stronger H2 2026.

RaySearch Laboratories (Q2 Initial take): Confidence in a strong H2